Olink : Biomarkers of drug action in phase 2 studies of Povorcitinib

Share





share on facebook


share on twitter
... | May 12, 2023

Related Keywords

,Incyte Corporation Wilmington ,Incyte Corporation ,Janus Kinase ,Hidradenitis Suppurativa ,Olink Holding Ab Publ Stock Exchange ,News ,Information ,Press Release ,Phare ,N ,N Olk Us6807101000 ,